FDA Inspection 899155 — Binh Bui-Nguyen, MD
The FDA completed an inspection of Binh Bui-Nguyen, MD on September 19, 2014 in Bordeaux. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 19, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bordeaux (France)
Additional Details
Clinical Investigator (CI)